Witnessing the stock’s movement on the chart, on Tuesday, Oncolytics Biotech, Inc (NASDAQ: ONCY) set off with pace as it heaved 7.09% to $0.97, before settling in for the price of $0.91 at the close. Taking a more long-term approach, ONCY posted a 52-week range of $0.71-$1.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 18.01%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -0.20%. This publicly-traded company’s shares outstanding now amounts to $77.07 million, simultaneously with a float of $75.99 million. The organization now has a market capitalization sitting at $75.53 million. At the time of writing, stock’s 50-day Moving Average stood at $1.0279, while the 200-day Moving Average is $1.0378.
Oncolytics Biotech, Inc (ONCY) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Oncolytics Biotech, Inc’s current insider ownership accounts for 1.40%, in contrast to 1.62% institutional ownership.
Oncolytics Biotech, Inc (ONCY) Earnings and Revenue Records
Oncolytics Biotech, Inc’s EPS decrease for this current 12-month fiscal period is -0.20% and is forecasted to reach -0.33 in the upcoming year.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Trading Performance Indicators
Let’s observe the current performance indicators for Oncolytics Biotech, Inc (ONCY). It’s Quick Ratio in the last reported quarter now stands at 2.99. The Stock has managed to achieve an average true range (ATR) of 0.07.
In the same vein, ONCY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.27, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.33 at the market close of one year from today.
Technical Analysis of Oncolytics Biotech, Inc (ONCY)
Going through the that latest performance of [Oncolytics Biotech, Inc, ONCY]. Its last 5-days volume of 1.11 million indicated improvement to the volume of 0.35 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 77.79% While, its Average True Range was 0.0819.
Raw Stochastic average of Oncolytics Biotech, Inc (ONCY) in the period of the previous 100 days is set at 31.70%, which indicates a major fall in contrast to 93.25% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 101.95% that was higher than 79.09% volatility it exhibited in the past 100-days period.
